Here's a breakdown of the market predictions from J.P. Morgan on what to expect for the remainder of the year.

U.S. Antiarrhythmic Drugs Market to Reach USD 0.51 Billion by 2032, Growing at 6.28% CAGR as Hospitals and Healthcare Providers Expand Access to Life-Saving Antiarrhythmic Therapies.Pune, Sept. 12, ...